1
|
Majumdar MK, Banks V, Peluso DP and Morris
EA: Isolation, characterization, and chondrogenic potential of
human bone marrow-derived multipotential stromal cells. J Cell
Physiol. 185:98–106. 2000. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: Implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
3
|
Halvorsen YC, Wilkison WO and Gimble JM:
Adipose-derived stromal cells - their utility and potential in bone
formation. Int J Obes Relat Metab Disord. 24 Suppl 4:S41–S44. 2000.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Halvorsen YD, Franklin D, Bond AL, Hitt
DC, Auchter C, Boskey AL, Paschalis EP, Wilkison WO and Gimble JM:
Extracellular matrix mineralization and osteoblast gene expression
by human adipose tissue-derived stromal cells. Tissue Eng.
7:729–741. 2001. View Article : Google Scholar : PubMed/NCBI
|
5
|
Rangappa S, Fen C, Lee EH, Bongso A and
Sim EK: Transformation of adult mesenchymal stem cells isolated
from the fatty tissue into cardiomyocytes. Ann Thorac Surg.
75:775–779. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Planat-Benard V, Silvestre JS, Cousin B,
André M, Nibbelink M, Tamarat R, Clergue M, Manneville C,
Saillan-Barreau C, Duriez M, et al: Plasticity of human adipose
lineage cells toward endothelial cells: Physiological and
therapeutic perspectives. Circulation. 109:656–663. 2004.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Konno M, Hamazaki TS, Fukuda S, Tokuhara
M, Uchiyama H, Okazawa H, Okochi H and Asashima M: Efficiently
differentiating vascular endothelial cells from adipose
tissue-derived mesenchymal stem cells in serum-free culture.
Biochem Biophys Res Commun. 400:461–465. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Konno M, Hamabe A, Hasegawa S, Ogawa H,
Fukusumi T, Nishikawa S, Ohta K, Kano Y, Ozaki M, Noguchi Y, et al:
Adipose-derived mesenchymal stem cells and regenerative medicine.
Dev Growth Differ. 55:309–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Banas A, Teratani T, Yamamoto Y, Tokuhara
M, Takeshita F, Quinn G, Okochi H and Ochiya T: Adipose
tissue-derived mesenchymal stem cells as a source of human
hepatocytes. Hepatology. 46:219–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Casteilla L and Dani C: Adipose
tissue-derived cells: From physiology to regenerative medicine.
Diabetes Metab. 32:393–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
D'Andrea F, De Francesco F, Ferraro GA,
Desiderio V, Tirino V, De Rosa A and Papaccio G: Large-scale
production of human adipose tissue from stem cells: A new tool for
regenerative medicine and tissue banking. Tissue Eng Part C
Methods. 14:233–242. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kawamoto K, Yabe S, Konno M, Ishii H,
Nishida N, Koseki J, Fukuda S, Tomimaru Y, Hama N, Wada H, et al:
Murine insulinoma cell-conditioned medium with BETA2/Neurod1
transduction efficiently induces the differentiation of
adipose-derived mesenchymal stem cells into β-Like cells both in
vitro and in vivo. J Stem Cell Res Ther. 4:10002212014. View Article : Google Scholar
|
13
|
Shiojiri N, Takeshita K, Yamasaki H and
Iwata T: Suppression of C/EBP alpha expression in biliary cell
differentiation from hepatoblasts during mouse liver development. J
Hepatol. 41:790–798. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Yamasaki H, Sada A, Iwata T, Niwa T,
Tomizawa M, Xanthopoulos KG, Koike T and Shiojiri N: Suppression of
C/EBPalpha expression in periportal hepatoblasts may stimulate
biliary cell differentiation through increased Hnf6 and Hnf1b
expression. Development. 133:4233–4243. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
McCright B, Lozier J and Gridley T: A
mouse model of Alagille syndrome: Notch2 as a genetic modifier of
Jag1 haploinsufficiency. Development. 129:1075–1082.
2002.PubMed/NCBI
|
16
|
Tanimizu N and Miyajima A: Notch signaling
controls hepatoblast differentiation by altering the expression of
liver-enriched transcription factors. J Cell Sci. 117:3165–3174.
2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Clotman F, Jacquemin P, Plumb-Rudewiez N,
Pierreux CE, Van der Smissen P, Dietz HC, Courtoy PJ, Rousseau GG
and Lemaigre FP: Control of liver cell fate decision by a gradient
of TGF beta signaling modulated by Onecut transcription factors.
Genes Dev. 19:1849–1854. 2005. View Article : Google Scholar : PubMed/NCBI
|